Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Palatin releases updated results from responder analyses of phase 3 Melody-1 trial in dry eye
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Regeneron to highlight real-world efficacy of aflibercept 8 mg (EYLEA HD) in wAMD, DME, and DR
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Red light therapy in children with myopia
Allotex appoints Michael Mrochen as CEO